Y25130 hydrochloride, a selective 5HT3 receptor antagonist has potent antimitogenic and apoptotic effect on HT29 colorectal cancer cell line

European Journal of Cancer Prevention

Volumn 19, Issue 2, 2010, Pages 138-143

  Ataee, Ramin ^a,c   Ajdary, Soheila ^a,c   Zarrindast, Mohammadreza ^c   Rezayat, Mehdi ^c   Shokrgozar, Mohammad Ali ^b   Ataee, Amin ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agonist and antagonists; Apoptosis; Cell cycle arrest; Proliferation; Receptors; Serotonin

Indexed keywords

AZASETRON; CISAPERIDE; PHENYLBIGUANIDE; RS 2397190; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL;

ANTIMITOTIC AGENTS; APOPTOSIS; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; HUMANS; MICROSCOPY, FLUORESCENCE; OXAZINES; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TUMOR CELLS, CULTURED;

EID: 76449113370     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283354901     Document Type: Article

References (32)

1. Banes AKL, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D, Marrero MB (2005). Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 288:C805-C812.
2. Blask DE, Hill SM (1986). Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm 21:433-449.
3. Bradford MM (1996). A rapid and sensitive method for the quantitition of microgram quantities of protein utilizing the principle of dye-binding. Anal Biochem 72:248-254.
4. Cattaneo MG, Codignola A, Vicentini LM, Clementi F, Sher E (1993). Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res 53:5566-5568.
5. Cattaneo MG, Fesce R, Vicentini LM (1995). Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. Eur J Pharmacol 291:209-211.
6. Dizeyi N, Bjartell A, Nilsson E, Hansson J, Gadaleanu V, Cross N, Abrahamsson PA (2004). Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate 59:328-336.
7. El-Salhy M (2005). Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer. Curr Pharm Des 11:2107-2117. (Pubitemid 40766845)
8. El-Salhy M, Norrgard O, Bostrom A (1998). Low levels of colonic somatostatin and galanin in patients with colon carcinoma. GI Cancer 2:221-225. (Pubitemid 28234049)
9. El-Salhy M, Sitohy B, Norrgard O (2003). Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma. Regul Pept 111:145-152.
10. El-Salhy M, Hilding L, Royson H, Tjomsland V (2005). Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer. Int J Oncol 27:687-691.
11. Hilakivi-Clarke L,Wright A, Lippman ME (1993). DMBA-induced mammary tumor growth in rats exhibiting increased or decreased ability to cope with stress due to early postnatal handling or antidepressant treatment. Physiol Behav 54:229-236.
12. Hill DJ (1991). Neuropeptides and cell proliferation. In: Daniel EE, editor. Neuropeptides function in gastrointestinal tract. Boca Raton: CRC Press; pp. 479-490.
13. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. (1994). VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
14. Huerta S, Goulet EJ, Livingston EH (2006). Colon cancer and apoptosis. Am J Surg 191:517-526.
15. Ishizuka J, Beauchamp RD, Townsend CM Jr, Greele GH Jr, Thompson JC (1992). Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol 150:1-7.
16. Launay JM, Birraux G, Bondoux D, Callebert J, Choi DS, Loric S, Maroteaux L (1996). Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem 271:3141-3147.
17. Luis B, Miguel G, Veró nica D, Gloria R, Julio L, Juan LC, Aurelio C. (2009). Incidence and mortality by colorectal cancer in Spain during 1951-2006 and its relationship with behavioural factors. Eur J Cancer Prev 18:436-444.
18. Maxwell PD, Anne-Helene O, Peter S (2009). The potential for prevention of colorectal cancer in the UK. Eur J Cancer Prev 18:179-190.
19. Midgley R, Kerr D (1999). Colorectal cancer. Lancet 353:391-399.
20. Pantaleo MA, Palassini E, Labianca R, Biasco G (2006). Targeted therapy in colorectal cancer: do we know enough? Dig Liver Dis 38:71-77.
21. Pezzella G, Moslinger-Gehmayr R, Contu A (2001). Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 70:1-10.
22. Pourgholami MH, Akhter J,Wang L, Lu Y, Morris DL (2005). Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol 55:425-432.
23. Roth BL (1994). Multiple serotonin receptors: clinical and experimental aspects. Ann Clin Psychiatry J Am Acad Clin Psychiatr 6:67-78.
24. Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF (2002). The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer 86:92-97.
25. Siddiqui EJ, Shabbir MA, Mikhailidis DP, Mumtaz FH, Thompson CS (2006). The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation. BJU Int 97:634-639.
26. Sonier B, Lavigne C, Arseneault M, Ouellette R, Vaillancourt C (2005). Expression of the 5-HT2A serotoninergic receptor in human placenta and choriocarcinoma cells: mitogenic implications of serotonin. Placenta 26:484-490.
27. Sonier B, Arseneault M, Lavigne C, Ouellette RJ, Vaillancourt C (2006). The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun 343:1053-1059.
28. Tjomsland V, El-Salhy M (2005). Anti-tumour effects of triple therapy with octreotide, galanin and serotonin in comparison with those of 5-fluorouracil/ leukovorin on human colon cancer. Int J Oncol 27:427-432.
29. Van Steenbergen Liza N, Lemmens Valery EPP, Louwman Marieke J, Straathof Jan Willem A, Coebergh J-WW (2009). Increasing incidence and decreasing mortality of colorectal cancer due to marked cohort effects in southern Netherlands. Eur J Cancer Prev 18:145-152.
30. Weigent DA, Blalock JE (1995). Associations between the neuroendocrine and immune systems. J Leukoc Biol 58:137-150.
31. Wilkinson LO, Dourish CT (1991). Basic and clinical aspects. In: Peroutka SJ, editor. Serotonin receptor subtypes. Vol.15. New York: John Wiley & Sons; pp. 147-210.
32. Yue CT, Liu YL (2005). Fluoxetine increases extracellular levels of 3-methoxy-4-hydroxyphenylglycol in cultured COLO320 DM cells. Cell Biochem Funct 23:109-114.